From: RANKL blockade alleviates peri-implant bone loss and is enhanced by anti-inflammatory microRNA-146a through TLR2/4 signaling
Total implants
Lost
Loose
Osseointegrated
Success rate (%)
SR P value
Wild type group
60
6
5
49
81.67
0.595
TLR2/4 KO group
4
52
86.67